Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Pastoral production is associated with increased peste des petits ruminants seroprevalence in northern Tanzania across sheep, goats and cattle.

Herzog CM, de Glanville WA, Willett BJ, Kibona TJ, Cattadori IM, Kapur V, Hudson PJ, Buza J, Cleaveland S, Bjørnstad ON.

Epidemiol Infect. 2019 Jan;147:e242. doi: 10.1017/S0950268819001262.

PMID:
31364555
2.

Stochastic changes in gene expression promote chaotic dysregulation of homeostasis in clonal breast tumors.

Felts SJ, Tang X, Willett B, Van Keulen VP, Hansen MJ, Kalari KR, Pease LR.

Commun Biol. 2019 Jun 14;2:206. doi: 10.1038/s42003-019-0460-0. eCollection 2019.

3.

Transmission ecology of canine parvovirus in a multi-host, multi-pathogen system.

Behdenna A, Lembo T, Calatayud O, Cleaveland S, Halliday JEB, Packer C, Lankester F, Hampson K, Craft ME, Czupryna A, Dobson AP, Dubovi EJ, Ernest E, Fyumagwa R, Hopcraft JGC, Mentzel C, Mzimbiri I, Sutton D, Willett B, Haydon DT, Viana M.

Proc Biol Sci. 2019 Mar 27;286(1899):20182772. doi: 10.1098/rspb.2018.2772.

PMID:
30914008
4.

SMS-based smartphone application for disease surveillance has doubled completeness and timeliness in a limited-resource setting - evaluation of a 15-week pilot program in Central African Republic (CAR).

El-Khatib Z, Shah M, Zallappa SN, Nabeth P, Guerra J, Manengu CT, Yao M, Philibert A, Massina L, Staiger CP, Mbailao R, Kouli JP, Mboma H, Duc G, Inagbe D, Barry AB, Dumont T, Cavailler P, Quere M, Willett B, Reaiche S, de Ribaucourt H, Reeder B.

Confl Health. 2018 Oct 24;12:42. doi: 10.1186/s13031-018-0177-6. eCollection 2018.

5.

Structure-Guided Identification of a Nonhuman Morbillivirus with Zoonotic Potential.

Abdullah N, Kelly JT, Graham SC, Birch J, Gonçalves-Carneiro D, Mitchell T, Thompson RN, Lythgoe KA, Logan N, Hosie MJ, Bavro VN, Willett BJ, Heaton MP, Bailey D.

J Virol. 2018 Nov 12;92(23). pii: e01248-18. doi: 10.1128/JVI.01248-18. Print 2018 Dec 1.

6.

Copper-Catalyzed Formal [4+2] Cycloaddition of Enoldiazoimides with Sulfur Ylides.

Cheng QQ, Massey LA, Willett BS, Deng Y, Arman H, Doyle MP.

Angew Chem Int Ed Engl. 2018 Aug 6;57(32):10343-10346. doi: 10.1002/anie.201805323. Epub 2018 Jul 9.

7.

The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?

Hosie MJ, Techakriengkrai N, Bęczkowski PM, Harris M, Logan N, Willett BJ.

Vet Sci. 2017 Jan 28;4(1). pii: E7. doi: 10.3390/vetsci4010007. Review.

8.

Future research to underpin successful peste des petits ruminants virus (PPRV) eradication.

Baron MD, Diop B, Njeumi F, Willett BJ, Bailey D.

J Gen Virol. 2017 Nov;98(11):2635-2644. doi: 10.1099/jgv.0.000944. Epub 2017 Oct 12. Review.

9.

Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes.

Logan N, Dundon WG, Diallo A, Baron MD, James Nyarobi M, Cleaveland S, Keyyu J, Fyumagwa R, Hosie MJ, Willett BJ.

Vaccine. 2016 Nov 11;34(47):5736-5743. doi: 10.1016/j.vaccine.2016.10.010. Epub 2016 Oct 11.

10.

Protection of Cattle against Rinderpest by Vaccination with Wild-Type but Not Attenuated Strains of Peste des Petits Ruminants Virus.

Holzer B, Hodgson S, Logan N, Willett B, Baron MD.

J Virol. 2016 Apr 29;90(10):5152-5162. doi: 10.1128/JVI.00040-16. Print 2016 May 15.

11.

Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies.

Logan N, McMonagle E, Drew AA, Takahashi E, McDonald M, Baron MD, Gilbert M, Cleaveland S, Haydon DT, Hosie MJ, Willett BJ.

Vaccine. 2016 Feb 3;34(6):814-22. doi: 10.1016/j.vaccine.2015.12.006. Epub 2015 Dec 17.

12.

Determination of kQ using MLC-collimated rectangular fields for absolute dosimetry of the CyberKnife.

Gersh JA, Willett B.

J Appl Clin Med Phys. 2015 Nov 8;16(6):273–280. doi: 10.1120/jacmp.v16i6.5720.

13.

"Lagrangian" for a Non-Lagrangian Field Theory with N=2 Supersymmetry.

Gadde A, Razamat SS, Willett B.

Phys Rev Lett. 2015 Oct 23;115(17):171604. doi: 10.1103/PhysRevLett.115.171604. Epub 2015 Oct 23.

PMID:
26551100
14.

In memoriam--Richard M. Elliott (1954-2015).

Brennan B, Weber F, Kormelink R, Schnettler E, Bouloy M, Failloux AB, Weaver SC, Fazakerley JK, Fragkoudis R, Harris M, Barr JN, Palese P, García-Sastre A, Dalziel RG, Dutia BM, Lowen AC, Steel J, Randall RE, Paul Duprex W, Rice CM, Tesh RB, Murphy FA, Ebihara H, Vasconcelos PF, Nunes MR, Fooks AR, Smith GL, Goodfellow I, Pappu HR, Lamb RA, Paterson RG, Higgs S, Vanlandingham DL, Dietzgen RG, Stephen Lodmell J, Nichol ST, Daly J, Ullman DE, Plyusnin A, Plyusnina A, Efstathiou S, Hewson R, Tordo N, Cherry S, Boutell C, Hosie MJ, Murcia PR, Neil JC, Palmarini M, Patel AH, Willett BJ, Kohl A, McLauchlan J.

J Gen Virol. 2015 Aug;96(8):1975-8. doi: 10.1099/jgv.0.000241. No abstract available.

15.

Feline immunodeficiency virus (FIV) env recombinants are common in natural infections.

Bęczkowski PM, Hughes J, Biek R, Litster A, Willett BJ, Hosie MJ.

Retrovirology. 2014 Sep 17;11:80. doi: 10.1186/s12977-014-0080-1.

16.

Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.

Bęczkowski PM, Harris M, Techakriengkrai N, Beatty JA, Willett BJ, Hosie MJ.

Vaccine. 2015 Feb 18;33(8):977-84. doi: 10.1016/j.vaccine.2015.01.028. Epub 2015 Jan 19.

17.

Dynamics of a morbillivirus at the domestic-wildlife interface: Canine distemper virus in domestic dogs and lions.

Viana M, Cleaveland S, Matthiopoulos J, Halliday J, Packer C, Craft ME, Hampson K, Czupryna A, Dobson AP, Dubovi EJ, Ernest E, Fyumagwa R, Hoare R, Hopcraft JG, Horton DL, Kaare MT, Kanellos T, Lankester F, Mentzel C, Mlengeya T, Mzimbiri I, Takahashi E, Willett B, Haydon DT, Lembo T.

Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1464-9. doi: 10.1073/pnas.1411623112. Epub 2015 Jan 20.

18.

Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).

Bęczkowski PM, Litster A, Lin TL, Mellor DJ, Willett BJ, Hosie MJ.

Vet Microbiol. 2015 Mar 23;176(1-2):50-60. doi: 10.1016/j.vetmic.2014.12.023. Epub 2015 Jan 3.

19.

Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus.

Bęczkowski PM, Hughes J, Biek R, Litster A, Willett BJ, Hosie MJ.

J Gen Virol. 2015 Apr;96(Pt 4):893-903. doi: 10.1099/vir.0.000035. Epub 2014 Dec 22.

20.

Comparing the efficacy of FeLV vaccines: comment on: Stuke, K. et al. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum age cats following virulent FeLV challenge. Vaccine 2014;32(22):2599-603.

Hofmann-Lehmann R, Levy LS, Willett BJ.

Vaccine. 2015 Jun 4;33(24):2737-8. doi: 10.1016/j.vaccine.2014.10.038. Epub 2014 Nov 15. No abstract available.

PMID:
25444783
21.

Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats.

Bęczkowski PM, Techakriengkrai N, Logan N, McMonagle E, Litster A, Willett BJ, Hosie MJ.

Retrovirology. 2014 Nov 28;11:95. doi: 10.1186/s12977-014-0095-7.

22.

An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus.

Bęczkowski PM, Logan N, McMonagle E, Litster A, Willett BJ, Hosie MJ.

J Gen Virol. 2015 Mar;96(Pt 3):671-80. doi: 10.1099/vir.0.071522-0. Epub 2014 Nov 13.

23.

Host and viral determinants of Mx2 antiretroviral activity.

Busnadiego I, Kane M, Rihn SJ, Preugschas HF, Hughes J, Blanco-Melo D, Strouvelle VP, Zang TM, Willett BJ, Boutell C, Bieniasz PD, Wilson SJ.

J Virol. 2014 Jul;88(14):7738-52. doi: 10.1128/JVI.00214-14. Epub 2014 Apr 23.

24.

The virus-receptor interaction in the replication of feline immunodeficiency virus (FIV).

Willett BJ, Hosie MJ.

Curr Opin Virol. 2013 Dec;3(6):670-5. doi: 10.1016/j.coviro.2013.08.003. Epub 2013 Aug 28. Review.

25.

Genetic imprint of vaccination on simian/human immunodeficiency virus type 1 transmitted viral genomes in rhesus macaques.

Varela M, Verschoor E, Lai RP, Hughes J, Mooj P, McKinley TJ, Fitzmaurice TJ, Landskron L, Willett BJ, Frost SD, Bogers WM, Heeney JL.

PLoS One. 2013 Aug 14;8(8):e70814. doi: 10.1371/journal.pone.0070814. eCollection 2013.

26.

Complete genome sequences of two feline leukemia virus subgroup B isolates with novel recombination sites.

Stewart H, Jarrett O, Hosie MJ, Willett BJ.

Genome Announc. 2013 Jan;1(1). pii: e00036-12. doi: 10.1128/genomeA.00036-12. Epub 2013 Jan 15.

27.

Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies.

Willett BJ, Kraase M, Logan N, McMonagle E, Varela M, Hosie MJ.

PLoS One. 2013;8(1):e54871. doi: 10.1371/journal.pone.0054871. Epub 2013 Jan 23.

28.

Recent developments in human immunodeficiency virus-1 latency research.

Chan CN, Dietrich I, Hosie MJ, Willett BJ.

J Gen Virol. 2013 May;94(Pt 5):917-32. doi: 10.1099/vir.0.049296-0. Epub 2013 Jan 30. Review.

29.

Prostratin exhibits both replication enhancing and inhibiting effects on FIV infection of feline CD4+ T-cells.

Chan CN, McMonagle EL, Hosie MJ, Willett BJ.

Virus Res. 2013 Jan;171(1):121-8. doi: 10.1016/j.virusres.2012.11.004. Epub 2012 Nov 28.

30.

Feline leukaemia virus: half a century since its discovery.

Willett BJ, Hosie MJ.

Vet J. 2013 Jan;195(1):16-23. doi: 10.1016/j.tvjl.2012.07.004. Epub 2012 Aug 3. Review.

PMID:
22867855
31.
32.

Diverse HIV viruses are targeted by a conformationally dynamic antiviral.

Caines ME, Bichel K, Price AJ, McEwan WA, Towers GJ, Willett BJ, Freund SM, James LC.

Nat Struct Mol Biol. 2012 Mar 11;19(4):411-6. doi: 10.1038/nsmb.2253.

33.

Feline immunodeficiency virus (FIV) neutralization: a review.

Hosie MJ, Pajek D, Samman A, Willett BJ.

Viruses. 2011 Oct;3(10):1870-90. doi: 10.3390/v3101870. Epub 2011 Oct 13. Review.

34.

Restriction of the felid lentiviruses by a synthetic feline TRIM5-CypA fusion.

Dietrich I, McEwan WA, Hosie MJ, Willett BJ.

Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):235-42. doi: 10.1016/j.vetimm.2011.06.017. Epub 2011 Jun 12. Review.

35.

Are endogenous feline leukemia viruses really endogenous?

Stewart H, Jarrett O, Hosie MJ, Willett BJ.

Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):325-31. doi: 10.1016/j.vetimm.2011.06.011. Epub 2011 Jun 12.

PMID:
21715022
36.

The role of BST2/tetherin in feline retrovirus infection.

Dietrich I, Hosie MJ, Willett BJ.

Vet Immunol Immunopathol. 2011 Oct 15;143(3-4):255-64. doi: 10.1016/j.vetimm.2011.06.020. Epub 2011 Jun 12. Review.

37.

Isolation and partial characterization of Brazilian samples of feline immunodeficiency virus.

Teixeira BM, Logan N, Samman A, Miyashiro SI, Brandão PE, Willett BJ, Hosie MJ, Hagiwara MK.

Virus Res. 2011 Sep;160(1-2):59-65. doi: 10.1016/j.virusres.2011.05.007. Epub 2011 May 17.

38.

Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.

Dietrich I, McMonagle EL, Petit SJ, Vijayakrishnan S, Logan N, Chan CN, Towers GJ, Hosie MJ, Willett BJ.

J Virol. 2011 Jun;85(12):5840-52. doi: 10.1128/JVI.00071-11. Epub 2011 Apr 13.

39.

Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom.

Samman A, McMonagle EL, Logan N, Willett BJ, Biek R, Hosie MJ.

Vet Microbiol. 2011 Jun 2;150(3-4):239-47. doi: 10.1016/j.vetmic.2011.01.027. Epub 2011 Feb 1.

40.

Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion.

Dietrich I, Macintyre A, McMonagle E, Price AJ, James LC, McEwan WA, Hosie MJ, Willett BJ.

J Virol. 2010 Sep;84(17):8980-5. doi: 10.1128/JVI.00858-10. Epub 2010 Jun 16.

41.

Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Willett BJ, Kraase M, Logan N, McMonagle EL, Samman A, Hosie MJ.

Retrovirology. 2010 Apr 26;7:38. doi: 10.1186/1742-4690-7-38.

42.

Genetic diversity of Brazilian isolates of feline immunodeficiency virus.

Teixeira BM, Logan N, Cruz JC, Reis JK, Brandão PE, Richtzenhain LJ, Hagiwara MK, Willett BJ, Hosie MJ.

Arch Virol. 2010 Mar;155(3):379-84. doi: 10.1007/s00705-009-0587-2. No abstract available.

PMID:
20084530
43.

Feline immunodeficiency virus env gene evolution in experimentally infected cats.

Kraase M, Sloan R, Klein D, Logan N, McMonagle L, Biek R, Willett BJ, Hosie MJ.

Vet Immunol Immunopathol. 2010 Mar 15;134(1-2):96-106. doi: 10.1016/j.vetimm.2009.10.015. Epub 2009 Nov 7.

PMID:
19897254
44.

Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of Env.

Samman A, Logan N, McMonagle EL, Ishida T, Mochizuki M, Willett BJ, Hosie MJ.

J Gen Virol. 2010 Jan;91(Pt 1):242-9. doi: 10.1099/vir.0.015404-0. Epub 2009 Sep 23.

PMID:
19776242
45.

Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat.

McEwan WA, Schaller T, Ylinen LM, Hosie MJ, Towers GJ, Willett BJ.

J Virol. 2009 Aug;83(16):8270-5. doi: 10.1128/JVI.00670-09. Epub 2009 Jun 3.

46.

Lymphocyte migration through the blood-brain barrier (BBB) in feline immunodeficiency virus infection is significantly influenced by the pre-existence of virus and tumour necrosis factor (TNF)-alpha within the central nervous system (CNS): studies using an in vitro feline BBB model.

Fletcher NF, Bexiga MG, Brayden DJ, Brankin B, Willett BJ, Hosie MJ, Jacque JM, Callanan JJ.

Neuropathol Appl Neurobiol. 2009 Dec;35(6):592-602. doi: 10.1111/j.1365-2990.2009.01031.x. Epub 2009 May 26.

PMID:
19486302
47.

Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection.

Shalev Z, Duffy SP, Adema KW, Prasad R, Hussain N, Willett BJ, Tailor CS.

J Virol. 2009 Jul;83(13):6706-16. doi: 10.1128/JVI.02317-08. Epub 2009 Apr 15.

48.

Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus.

Willett BJ, McMonagle EL, Logan N, Schneider P, Hosie MJ.

Mol Immunol. 2009 Mar;46(6):1020-30. doi: 10.1016/j.molimm.2008.08.271. Epub 2009 Feb 1.

49.

A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.

Willett BJ, McMonagle EL, Logan N, Samman A, Hosie MJ.

Retrovirology. 2008 Aug 22;5:77. doi: 10.1186/1742-4690-5-77.

50.

Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors.

McEwan WA, McMonagle EL, Logan N, Serra RC, Kat P, Vandewoude S, Hosie MJ, Willett BJ.

J Virol. 2008 Nov;82(21):10953-8. doi: 10.1128/JVI.01312-08. Epub 2008 Aug 20.

Supplemental Content

Loading ...
Support Center